QA: AXIM Biotechnologies INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001514946_2018_AXIM_Biotechnologies_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001514946, AXIM Biotechnologies INC

  xvar xval
0 AssetsCurrent 2,112,594
1 IntangibleAssetsNetIncludingGoodwill 63,167
2 PropertyPlantAndEquipmentNet 8,949
3 remainder_Assets 7,440
4 LiabilitiesCurrent 7,705,120
5 LiabilitiesNoncurrent 771,523
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 42,857
8 SellingGeneralAndAdministrativeExpense 1,797,478
9 ResearchAndDevelopmentExpense 1,352,969
10 remainder_Expenses 3,356
11 remainder_Revenues 47,573
12 remainder_NetIncome -1,019,116
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,192,150
1 Liabilities 8,476,643
2 Expenses 3,196,660
3 Revenues 47,573
4 StockholdersEquity -6,284,493
5 NetIncome -4,168,203
6 ComprehensiveNetIncome -4,168,203
7 BaseVar 7,466,071
8 EconomicCapitalRatiobeforeLimitedLiability -3.35
9 EconomicCapitalRatio 0.575

Edgar->Model Mapping

Feature Distribution